Help: To find Illnesses or Conditions associated with a Herbal Remedy. Select a letter from A - Z of Herbal Remedies. Or Scroll lists. Or Use Search.

Nettle Remedies

Nettle - Herbal Research
A WHO Organizational resource: Nettle Research - FULL REPORT

Medicinal uses supported by clinical data
Symptomatic treatment of lower urinary tract disorders (nocturia, polyuria, urinary retention) resulting from BPH stages I and II, as defined by Alken, in cases where diagnosis of prostate cancer is negative (22-35).
Uses described in pharmacopoeias and traditional systems of medicine
As a diuretic and for the treatment of rheumatism and sciatica (6).
Uses described in folk medicine, not supported by experimental or clinical data
Treatment of asthma, coughs, dandruff, diabetes, diarrhoea, eczema, fever, gout, haemorrhoids, nose bleeds, scurvy, snakebites and tuberculosis (5, 6). The plant has also been used to stop uterine bleeding after childbirth, increase lactation and promote hair growth, and as a vermifuge (5, 6).


5. Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL, February 9, 1998 production (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network [STN] of Chemical Abstracts Services).
6. Patten G. Urtica. Australian Journal of Medical Herbalism, 1993, 5:5-13.
22. Bauer HW et al. Endokrine Parameter während der Behandlung der benignen Prostatahyperplasie mit ERU. In: Bauer HW, ed. Benigne Prostatahyperplasie II, klinische und experimentelle Urologie 19. Munich, Zuckschwerdt, 1988.
23. Belaiche P, Lievoux O. Clinical studies on the palliative treatment of prostatic adenoma with extract of Urtica root. Phytotherapy Research, 1991, 5:267-269.
24. Dathe G, Schmid H. Phytotherapie der benignen Prostatahyperplasie (BPH). Doppelblindstudie mit Extraktum Radicis Urticae (ERU). Urologie [B], 1987, 27:223-226.
25. Djulepa J. Zweijährige Erfahrung in der Therapie des Prosta-Syndroms. Ärztliche Praxis, 1982, 34:2199-2202.
26. Feiber H. Sonographische Verlaufsbeobachtungen zum Einfluss der medikamentösen Therapie der benignen Prostatahyperplasie (BPH). In: Bauer HW, ed. Benigne Prostatahyperplasie II, klinische und experimentelle Urologie 19. Munich, Zuckschwerdt, 1988.
27. Fisher M, Wilbert D. Wirkprüfung eines Phytopharmakons zur Behandlung der benignen Prostatahyperplasie (BPH). In: Rutishauser G, ed. Benigne Prostatahyperplasie III, klinische und experimentelle Urologie 22. Munich, Zuckschwerdt, 1992:79-83.
28. Friesen A. Statistische Analyse einer Multizenter-Langzeitstudie mit ERU. In: Bauer HW, ed. Benigne Prostatahyperplasie II, klinische und experimentelle Urologie 19. Munich, Zuckschwerdt, 1988:121-130.
29. Goetz P. Die Behandlung der benignen Prostatahyperplasie mit Brennesselwurzeln. Zeitschrift für Phytotherapie, 1989, 10:175-178.
30. Sonnenschein R. Untersuchung der Wirksamkeit eines prostatotropen Phytotherapeutikums (Urtica plus) bei benigner Prostatahyperplasie und Prostatitis - eine prospektive multizentrische Studie. Urologie [B], 1987, 27:232-237.
31. Stahl HP. Die Therapie prostatischer Nykturie. Zeitschrift für Allgemeine Medizin, 1984, 60:128-132.
32. Tosch U et al. Medikamentöse Behandlung der benignen Prostatahyperplasie. Euromed, 1983, 6:1-3.
33. Vahlensieck W. Konservative Behandlung der benignen Prostatahyperplasie. Therapiewoche Schweiz, 1986, 2:619-624.
34. Vandierendounck EJ, Burkhardt P. Extractum radicis urticae bei Fibromyoadenom der Prostata mit nächtlicher Pollakisurie. Therapiewoche Schweiz, 1986, 2:892-895.
35. Vontobel HP et al. Ergebnisse einer Doppelblindstudie über die Wirksamkeit von ERU-Kapseln in der konservativen Behandlung der benignen Prostatahyperplasie. Urologie [A], 1985, 24:49-51.

Health Issues

Mother Nature could have the answer to treating several causes of blindness, according to a ground-breaking study involving scientists from the University of Surrey


A $5.7 billion global medical bill to restore sight for the estimated 45 million people with cataracts could be slashed in half by a diet rich in colourful fruits and vegetables, according to an international study.


UK-based trade group the Health Food Manufacturers Association (HFMA) has written a formal letter of complaint to the BBC about a controversial BBC2 Horizon programme about the food supplements industry.